Sanger Sequencing Service Market By Manufacturers, By End-user (Diagnostics, Biomarkers & Cancer, Reproductive Health, Personalized Medicine, Forensics, Others), By End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals & Clinics), and By Regions (North America, Europe, Middle East and Africa, Latin America and Asia Pacific) - Global Outlook to 2026
Report ID: 391251 | Feb 2020 | No. of Pages: 120 |
Covid-19 Impact Analysis & Forecast
Global Sanger Sequencing Service Market is valued USD 75.32 Billion in 2019 and is projected is to exhibit 0.5% CAGR during the forecast period. The market is projected to be around USD 78 Billion by 2026. The market is driven by the growing demand for pharmacogenomics in drug discovery & development.

Award-winning sanger sequencing services produce high-quality results, industry-leading customer service, and fast turnaround times at competitive prices. GENEWIZ is the partner of choice for academic, GLP, pharmaceutical, biotechnology, and government institutions around the world.
Sanger Sequencing Service Market Dynamics
The factors that drive the growth of the Sanger sequencing service market are such as the growing demand for pharmacogenomics in drug discovery & development, technological development, decreasing prices of sequencing, growing demand for affordable genotyping services, rising incidence, and awareness on genetic diseases and personalized medicine, and high use of genetic analysis in animals and plants. Furthermore, the advantages associated with Sanger’s sequencing, and the advance in genome mapping programs boost the growth of the Sanger’s sequencing services market.

Additionally, the rise in investment in R&D and an increase in sequencing end-users have supplemented the market growth. At the same time, the lack of skilled professionals and standardization concerns associated with sequencing procedures hamper the growth of the industry. The untapped potential of developing markets and the use of cloud computing as a potential data management service are supposed to provide profitable opportunities for market expansion.
Sanger Sequencing Service Market Insight
North America is estimated to account for the largest market share of the Sanger sequencing service market in 2017, followed by the Asia Pacific. China is projected to witness significant growth in the next few years, due to an increase in R&D investment and a surge in end-users of Sanger’s sequencing. Furthermore, the Chinese region presents remarkable opportunities for venture capitalists and investors, as the developed markets are comparatively saturated. Rise in collaborations, partnerships, and agreements among market players, the surge in government funding for translational research, improving healthcare infrastructure are expected to increase demand for Sanger sequencing services in the Asia Pacific region. An increase in competition in mature markets and relatively less-stringent regulations and data requirements as compared to developed nations are other key factors that make the Asia Pacific an attractive region for stakeholders.
Sanger Sequencing Service Market Segmentation
The global Sanger Sequencing Service Market is segmented into application, end-user, and region. On the basis of the application the market is divided into diagnostics, biomarkers & cancer, reproductive health, personalized medicine, forensics, others. Based on end-user the market is segmented into academic & government research institutes, pharmaceutical companies, biotechnology companies, hospitals & clinics. And based on the geography the market is further segregated into North America, Latin America, Europe and Asia Pacific.
Sanger Sequencing Service Market Competitive Landscape
The key players in Sanger Sequencing Service Market are listed as BioScience, GenScript Biotech Corporation, Thermo Fisher Scientific, Inc., LGC Science Group Limited, Fasteris SA, CeMIA SA, Quintara Biosciences, GenHunter Corporation, GENEWIZ, SciGenom Labs Pvt. Limited, and Microsynth AG. Inc., Nucleics, and Other.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
Chapter 4. Market Outlook
4.1. Market Dynamics
4.1.1. Market Drivers
4.1.2. Market Restraints
4.1.3. Market Opportunities
4.2. Porter’s Analysis
4.3. Value Chain Analysis
Chapter 5. Sanger Sequencing Service Market, By Application
5.1. Sanger Sequencing Service Market, By Application, 2018-2026
5.2. Diagnostics
5.3. Biomarkers & Cancer
5.4. Reproductive Health
5.5. Personalized Medicine
5.6. Forensics
5.7. Others
Chapter 6. Sanger Sequencing Service Market, By End-user
6.1. Sanger Sequencing Service Market, by End-user, 2018-2026
6.2. Academic & Government Research Institutes
6.3. Pharmaceutical Companies
6.4. Biotechnology Companies
6.5. Hospitals & Clinics
Chapter 7. Sanger Sequencing Service Market, By Region
7.1. Sanger Sequencing Service Market, by Region, 2018-2026
7.1.1. North America U.S Rest of North America
7.1.2. Europe U.K. Germany France Rest of the Europe
7.1.3. Middle East & Africa (MEA) GCC North Africa South Africa Rest of MEA
7.1.4. Latin America (LATAM) Brazil Rest of LATAM
7.1.5. Asia Pacific (APAC) India China Japan Rest of the APAC
Chapter 8. Competitive Landscape
8.1.1. Key Strategies Adopted by Players
8.1.2. Market Share/Positioning Analysis
Chapter 9. Company Profiles
9.1. BioScience
9.1.1. Company Overview
9.1.2. Product Offerings
9.1.3. Financial Performance
9.1.4. Recent Initiatives
9.2. GenScript Biotech Corporation
9.2.1. Company Overview
9.2.2. Product Offerings
9.2.3. Financial Performance
9.2.4. Recent Initiatives
9.3. Thermo Fisher Scientific, Inc.
9.3.1. Company Overview
9.3.2. Product Offerings
9.3.3. Financial Performance
9.3.4. Recent Initiatives
9.4. LGC Science Group Limited
9.4.1. Company Overview
9.4.2. Product Offerings
9.4.3. Financial Performance
9.4.4. Recent Initiatives
9.5 Fasteris SA
9.5.1. Company Overview
9.5.2. Product Offerings
9.5.3. Financial Performance
9.5.4. Recent Initiatives
9.6. CeMIA SA
9.6.1. Company Overview
9.6.2. Product Offerings
9.6.3. Financial Performance
9.6.4. Recent Initiatives
9.7. Quintara Biosciences
9.7.1. Company Overview
9.7.2. Product Offerings
9.7.3. Financial Performance
9.7.4. Recent Initiatives
9.8. GenHunter Corporation
9.8.1. Company Overview
9.8.2. Product Offerings
9.8.3. Financial Performance
9.8.4. Recent Initiatives
9.9.1. Company Overview
9.9.2. Product Offerings
9.9.3. Financial Performance
9.9.4. Recent Initiatives
9.10. SciGenom Labs Pvt. Limited
9.10.1. Company Overview
9.10.2. Product Offerings
9.10.3. Financial Performance
9.10.4. Recent Initiatives
9.11. Microsynth AG. Inc.
9.11.1. Company Overview
9.11.2. Product Offerings
9.11.3. Financial Performance
9.11.4. Recent Initiatives
9.12. Nucleics
9.12.1. Company Overview
9.12.2. Product Offerings
9.12.3. Financial Performance
9.12.4. Recent Initiatives
9.13. List of other companies
9.13.1. Company Overview
9.13.2. Product Offerings
9.13.3. Financial Performance
9.13.4. Recent Initiatives
Chapter 10. Appendix
10.1. About Us
10.2. Glossary of Terms

GenScript Biotech Corporation
Thermo Fisher Scientific, Inc.
LGC Science Group Limited
Fasteris SA, CeMIA SA
Quintara Biosciences
GenHunter Corporation
SciGenom Labs Pvt. Limited
Microsynth AG. Inc.

1. This report provides in depth analysis for changing competitive dynamics and keeps you ahead of competitors
2. Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market
3. It provides a forward looking perspective on different factors driving or restraining market growth
4. It provides an eight-year forecast assessed on the basis of how the market is expected to grow
5. It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of various market segment
6. Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Select License Type
USD $4250
USD $6250
Connect With Us


X-Ray Flat Panel Detector Market By Key Manufacturers, By Type (Amorphous Silicon (a-Si), Amorphous Selenium (a-Se), Complementary Metal Oxide Semiconductor (CMOS)), By Application (Medical, Orthopedic, Mammogram, Dental, Cardiac, Veterinary, Security) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Global Outlook to 2026
Publication Month: Oct 2020 | No. of Pages: 120
Buy Now
Tele-ICUe Market By Key Manufacturers, By Type (Hardware, Software), By Application (Hospitals, Disease Control and Prevention (CDC), Home Care) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Global Outlook to 2026
Publication Month: Oct 2020 | No. of Pages: 120
Buy Now
Tissue Engineered Skin Substitute Market By Key Manufacturers, By Type (Acellular, Cellular Allogeneic, Cellular Autologous, Others), By Application (Burn Injury, Diabetic, Vascular Ulcer, Others) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Global Outlook to 2026
Publication Month: Oct 2020 | No. of Pages: 120
Buy Now
MicroRNA Market By Key Manufacturers, By Type (PCR-based Assay, miRNA Arrays, Next Generation Sequencing (NGS), Immunoassay), By Application (Diagnostic Centers, Academic and Research Institutes, Biopharmaceutical Companies, Contract Research Organizations) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Global Outlook to 2026
Publication Month: Oct 2020 | No. of Pages: 120
Buy Now
Cell Sorter Market By Key Manufacturers, By Type (Cell Sorters, Cell Sorting Reagents & Consumables, Cell Sorting Services), By Application (Research Application, Clinical Applications) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Global Outlook to 2026
Publication Month: Oct 2020 | No. of Pages: 120
Buy Now